The proteasome inhibitor NPI-0052 is a more effective inducer of apoptosis than bortezomib in lymphocytes from patients with chronic lymphocytic leukemia. (Q50929139)
Jump to navigation
Jump to search
scientific article published in July 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The proteasome inhibitor NPI-0052 is a more effective inducer of apoptosis than bortezomib in lymphocytes from patients with chronic lymphocytic leukemia. |
scientific article published in July 2006 |
Statements
1 reference
The proteasome inhibitor NPI-0052 is a more effective inducer of apoptosis than bortezomib in lymphocytes from patients with chronic lymphocytic leukemia. (English)
1 reference
Michael Keating
1 reference
Stacey Ruiz
1 reference
Yelena Krupnik
1 reference
Joya Chandra
1 reference
Michael Palladino
1 reference
David McConkey
1 reference
1 July 2006
1 reference
5
1 reference
1836-1843
1 reference
7
1 reference
1 reference
Identifiers
1 reference